CTX-177

N/A

Report date: 2022/08/30 20:00:42
NME

Base Information

Drug NameCTX-177
Drug Alias NameONO-7018CTX-177ONO-7018
ClassificationSmall molecules
Mechanisms of ActionMucosa-associated lymphoid tissue lymphoma translocation protein 1 inhibitors
TargetsMucosa-associated lymphoid tissue lymphoma translocation protein 1
Therapy Area/IndicationsLymphoma, Non-HodgkinLymphomaLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesChordia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesChordia Therapeutics IncOno Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsLymphoma, Non-HodgkinLymphomaLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A